Similarly, in tumors, the inhibition of VEGF signaling leads to the reduction in immature (without pericyte coverage) tumor microvasculature with an increase in the percentage of vessels with pericyte coverage (mature vessels) [89,90]. The gene discussed is VEGFA; the disease is neoplasm.